Members Only Login
Virtual Education Series Archive:
Nobel Laureate & AFMR Member James B. Duke Professor of Medicine and Professor of Biochemistry and Chemistry at the Duke University Medical Center Dr. Lefkowitz will give the Presidential Plenary Lecture, A Tale of Two Callings, highlighting his career as a cardiologist and a biochemist. Learn more about Dr. Lefkowitz
PLENARY SESSION Introduction: Sidharth Mahapatra
The future of medical research will transcend randomized controlled trials and involve AI methodologies and digital twins. This session will discuss the concepts of artificial intelligence (AI) and data science, including their applications and limitations, and how to incorporate them into medical research effectively and ethically. Learn more about Dr. Chang
View the rest of 2023
October
Publication Workshop
Erge Edgu-Fry, PhD Managing Editor, Journal of Investigative Medicine Michael McPhaul Editor in Chief, Journal of Investigative Medicine High-Impact Case Reports
April
View Full Program Diversity, Equity, and Inclusion (DEI) Symposium
2022
2021
September
Dementia in the Oldest OldThursday, September 23, 2021
June
May
DECEMBER
Becoming a physician scientist: How to incorporate research into your medical training and career Monday December 7th 8:00 pm Eastern, 5:00 pm Pacific Speakers:
NOVEMBER
Alzheimer's Disease: Tau, Amyloid and Beyond – Toward Effective Treatment Wednesday, November 4th, 2020 12:00 pm-1:00 pm Eastern Lead: Allison B. Reiss, MD, AFMR National Council Councilor-at-Large, Editorial Board Member for Journal of Investigative Medicine, Journal of Investigative Medicine Description: Alzheimer's disease (AD) is the most common cause of progressive dementia, resulting in irreversible deterioration of brain function, cognition and memory. It is considered the sixth leading cause of death in the world. The global burden of AD is enormous and as the number of older persons increases over the next few decades, the number of AD cases is expected to skyrocket. Amyloid plaques and tau tangles are characteristic of AD. However, immunotherapy using antibodies which bind to amyloid or tau to promote their clearance has not proven effective as a therapy thus far. Researchers are struggling to develop ways to stop disease progression before people develop deficits in thinking and changes in personality. This webinar will discuss past disappointments and ways in which they may lead to future breakthroughs for preventing or slowing neuronal cell death using innovative approaches.
OCTOBER
An Abstract Review in Pulmonology Tuesday, October 20, 2020 6:00 pm-7:00 pm Eastern Lead: Theo Trandafirescu, MD — Eastern Region Council Chair Description: Presentations of 2-3 interesting clinical cases will be made with teaching points with follow-up audience discussion. Join Dr. Theo Trandafirescu, AFMR Eastern Section Council Chair, for a review of three Pulmonary cases. Cases to be Discussed:
Panel Members: Tracey O'Brien, Sofia Lakhdarand, Akwe Nyabera
SEPTEMBER
How to Write a Manuscript Workshop Tuesday, September 29, 2020 2:00 pm-3:30 pm Eastern Lead: Richard McCallum, MD - Editor-in-Chief, Journal of Investigative Medicine (JIM) Join Dr. Richard McCallum, Editor-in-Chief of the AFMR's Journal of Investigative Medicine, for a workshop on "How to Write a Manuscript". Each of the following sections will be given 15-20 minutes with 30 minutes left at the end for Q&A with Dr. McCallum.
AFMR National Office 500 Cummings Center, Suite 4400 Beverly, MA 01915 p: 978.927.8330 f: 978-524.0461 © 2025 American Federation for Medical Research. All Rights Reserved. Privacy Policy
